CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients
Yeonjoo Choi, Bhumsuk Keam, Miso Kim, Shinkyo Yoon, Dalyong Kim, Jong Gwon Choi, Ja Young Seo, Inkeun Park, Jae Lyun Lee
Cancer Research and Treatment. 2019;51(4):1549-1556.   Published online 2019 March 25    DOI: https://doi.org/10.4143/crt.2019.086

Excel Download

Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients
Yeonjoo Choi, Bhumsuk Keam, Miso Kim, Shinkyo Yoon, Dalyong Kim, Jong Gwon Choi, Ja Young Seo, Inkeun Park, Jae Lyun Lee
Cancer Research and Treatment. 2019;51(4):1549-1556   Crossref logo
Link1 Link2 Link3
Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures
Inkeun Park, Young Sup Shim, Heounjeong Go, Bum Sik Hong, Jae Lyun Lee
BMC Urology. 2019;19(1):   Crossref logo
Link1 Link2 Link3
Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma: A case report
Asher Goh, Benjamin Popp
Pathology. 2022;54:S44-S45   Crossref logo
Link1 Link2
Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma
Anna Caliò, Diego Segala, Guido Martignoni
Uropathology. 2020;143-145   Crossref logo
Link1
Fumarate hydratase-deficient renal cell carcinoma, including hereditary leiomyomatosis and renal cell carcinoma syndrome
Ming Zhou
Uropathology. 2023;338-339   Crossref logo
Link1 Link2
Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma
Anna Caliò, Diego Segala, Guido Martignoni
Encyclopedia of Pathology. 2019;1-3   Crossref logo
Link1
Hereditary Leiomyomatosis Renal Cell Carcinoma Syndrome
Diagnostic Pathology: Genitourinary. 2016;20-23   Crossref logo
Link1 Link2
Study comparing bevacizumab plus temsirolimus versus bevacizumab plus interferon-α in advanced renal cell carcinoma subjects (INTORACT)
Carrie Printz
Cancer. 2010;116(14):3309-3309   Crossref logo
Link1 Link2
5 Mechanism based targeted therapy for hereditary leiomyomatosis and renal cell cancer (HLRCC) and sporadic papillary renal cell carcinoma: interim results from a phase 2 study of bevacizumab and erlotinib
R. Srinivasan, D. Su, L. Stamatakis, M.M. Siddiqui, E. Singer, B. Shuch, J. Nix, J. Friend, G. Hawks, J. Shih, P. Choyke, W.M. Linehan
European Journal of Cancer. 2014;50:8   Crossref logo
Link1 Link2
The bevacizumab experience in advanced renal cell carcinoma
Lauren Harshman
OncoTargets and Therapy. 2010;179   Crossref logo
Link1
This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.